Two AI-driven disruptors, one biotech-focused, one software-first, post double-digit growth but diverge sharply on risk, cash ...

Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software ...

Move over Stray and Big Kitty, Little City, there's a new moggy-based game in town and it'll test your grey matter.

Detailed price information for Schrodinger Inc (SDGR-Q) from The Globe and Mail including charting and trades.

Detailed price information for Schrodinger Inc (SDGR-Q) from The Globe and Mail including charting and trades.

We live, eat, travel, and breathe in physical spaces, and no amount of algorithms and data centers will change that.

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...

Lilly’s Announced $2.3 Billion Acquisition of Ajax Validates Schrödinger’s Track Record of High-Value Collaborations NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

This study aims to explore the targets and mechanisms by which metformin (MET) exacerbates diabetic amyotrophy (DA) using a streptozotocin (STZ)-induced diabetic SD rat model. Although the ...

Schrodinger Inc. (NASDAQ:SDGR) is one of the best cancer stocks to invest in now. On February 25, Schrodinger Inc. (NASDAQ:SDGR) delivered solid fourth-quarter and full-year 2025 results characterized ...